Intracranial hypertension following highly active antiretroviral therapy interruption in an HIV-infected woman: case report and review of the literature

AIDS. 2013 Feb 20;27(4):668-70. doi: 10.1097/QAD.0b013e32835db0af.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • AIDS-Related Opportunistic Infections / complications*
  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / immunology
  • Acquired Immunodeficiency Syndrome / complications
  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Acquired Immunodeficiency Syndrome / immunology
  • Adenine / administration & dosage
  • Adenine / analogs & derivatives
  • Adult
  • Anti-HIV Agents / administration & dosage
  • Antiretroviral Therapy, Highly Active
  • Darunavir
  • Decompressive Craniectomy / methods*
  • Dideoxynucleosides / administration & dosage
  • Female
  • Humans
  • Intracranial Hypertension / etiology*
  • Intracranial Hypertension / immunology
  • Intracranial Hypertension / therapy
  • Intracranial Hypertension / virology
  • Lopinavir / administration & dosage
  • Medication Adherence*
  • Meningoencephalitis / complications
  • Meningoencephalitis / drug therapy
  • Meningoencephalitis / etiology*
  • Meningoencephalitis / immunology
  • Meningoencephalitis / virology
  • Organophosphonates / administration & dosage
  • Sulfonamides / administration & dosage
  • Tenofovir
  • Treatment Outcome

Substances

  • Anti-HIV Agents
  • Dideoxynucleosides
  • Organophosphonates
  • Sulfonamides
  • Lopinavir
  • Tenofovir
  • Adenine
  • abacavir
  • Darunavir